Literature DB >> 26157172

Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.

Susann Hüttl1, Kathrin Kläsener2, Michaela Schweizer3, Janna Schneppenheim4, Hans-Heinrich Oberg5, Dieter Kabelitz5, Michael Reth2, Paul Saftig1, Bernd Schröder6.   

Abstract

The invariant chain (CD74), a chaperone in MHC class II-mediated Ag presentation, is sequentially processed by different endosomal proteases. We reported recently that clearance of the final membrane-bound N-terminal fragment (NTF) of CD74 is mediated by the intramembrane protease signal peptide peptidase-like (SPPL)2a, a process critical for B cell development. In mice, SPPL2a deficiency provokes the accumulation of this NTF in endocytic vesicles, which leads to a B cell maturation arrest at the transitional 1 stage. To define the underlying mechanism, we analyzed the impact of SPPL2a deficiency on signaling pathways involved in B cell homeostasis. We demonstrate that tonic as well as BCR-induced activation of the PI3K/Akt pathway is massively compromised in SPPL2a(-/-) B cells and identify this as major cause of the B cell maturation defect in these mice. Altered BCR trafficking induces a reduction of surface IgM in SPPL2a-deficient B cells, leading to a diminished signal transmission via the BCR and the tyrosine kinase Syk. We provide evidence that in SPPL2a(-/-) mice impaired BCR signaling is to a great extent provoked by the accumulating CD74 NTF, which can interact with the BCR and Syk, and that impaired PI3K/Akt signaling and reduced surface IgM are not directly linked processes. In line with disturbances in PI3K/Akt signaling, SPPL2a(-/-) B cells show a dysregulation of the transcription factor FOXO1, causing elevated transcription of proapoptotic genes. We conclude that SPPL2a-mediated processing of CD74 NTF is indispensable to maintain appropriate levels of tonic BCR signaling to promote B cell maturation.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26157172     DOI: 10.4049/jimmunol.1403171

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors.

Authors:  Juraj Velcicky; Casey J N Mathison; Victor Nikulin; Daniel Pflieger; Robert Epple; Mihai Azimioara; Christopher Cow; Pierre-Yves Michellys; Pascal Rigollier; Daniel R Beisner; Ursula Bodendorf; Danilo Guerini; Bo Liu; Ben Wen; Samantha Zaharevitz; Trixi Brandl
Journal:  ACS Med Chem Lett       Date:  2019-05-23       Impact factor: 4.345

Review 2.  The immunobiology of ubiquitin-dependent B cell receptor functions.

Authors:  James R Drake
Journal:  Mol Immunol       Date:  2018-06-26       Impact factor: 4.407

Review 3.  The biological function and significance of CD74 in immune diseases.

Authors:  Huiting Su; Ning Na; Xiaodong Zhang; Yong Zhao
Journal:  Inflamm Res       Date:  2016-10-17       Impact factor: 4.575

4.  Measurement of CD74 N-terminal Fragment Accumulation in Cells Treated with SPPL2a Inhibitor.

Authors:  Rubén Martínez-Barricarte; Xiao-Fei Kong; Jean-Laurent Casanova
Journal:  Bio Protoc       Date:  2019-06-05

Review 5.  Invariant Chain Complexes and Clusters as Platforms for MIF Signaling.

Authors:  Robert Lindner
Journal:  Cells       Date:  2017-02-10       Impact factor: 6.600

6.  Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis.

Authors:  Torben Mentrup; Kosta Theodorou; Florencia Cabrera-Cabrera; Andreas O Helbig; Kathrin Happ; Marion Gijbels; Ann-Christine Gradtke; Björn Rabe; Akio Fukumori; Harald Steiner; Andreas Tholey; Regina Fluhrer; Marjo Donners; Bernd Schröder
Journal:  J Exp Med       Date:  2019-02-28       Impact factor: 14.307

Review 7.  Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer's Disease Genetics.

Authors:  Anna Podleśny-Drabiniok; Edoardo Marcora; Alison M Goate
Journal:  Trends Neurosci       Date:  2020-10-27       Impact factor: 16.978

Review 8.  Physiological functions of SPP/SPPL intramembrane proteases.

Authors:  Torben Mentrup; Florencia Cabrera-Cabrera; Regina Fluhrer; Bernd Schröder
Journal:  Cell Mol Life Sci       Date:  2020-02-12       Impact factor: 9.207

9.  The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis.

Authors:  Liza Rijvers; Marie-José Melief; Roos M van der Vuurst de Vries; Maeva Stéphant; Jamie van Langelaar; Annet F Wierenga-Wolf; Jeanet M Hogervorst; Anneke J Geurts-Moespot; Fred C G J Sweep; Rogier Q Hintzen; Marvin M van Luijn
Journal:  Eur J Immunol       Date:  2018-09-25       Impact factor: 5.532

Review 10.  Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases.

Authors:  Yang Zhou; Ying Zhang; Jinming Han; Mengge Yang; Jie Zhu; Tao Jin
Journal:  J Transl Med       Date:  2020-03-17       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.